Post by Boca Biolistics, LLC

Diagnostic validation studies rarely fail because of the assay alone. In many cases, the problems begin months earlier, during study planning. We've seen projects delayed because of: • Biospecimens that didn't reflect the intended patient population • Missing clinical annotation • Inconsistent sample quality • Underrepresentation of diverse patient cohorts • Validation planning that started too late By the time these issues are discovered, timelines, budgets, and regulatory milestones may already be at risk. That's why successful validation starts well before the first sample is tested. In this carousel, we've highlighted five common pitfalls—and how to avoid them. Which challenge has had the biggest impact on your diagnostic validation studies? We'd love to hear your perspective. #Diagnostics #IVD #PrecisionMedicine #Biomarkers #ClinicalResearch #Biospecimens #CompanionDiagnostics #Biotech